Clinical trial
Impact of Opioid Avoidance Protocol for ACL Reconstruction Surgery
NCT06340932 is registered in ClinicalTrials.gov with Matthew Varacallo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Opioid Avoidance Protocol for ACL Reconstruction Surgery
- Lead sponsor
- Matthew Varacallo
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 27, 2024
- Completion date
- February 1, 2025
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acl tear, post operative pain